Back to Results

Haoxi Health Technology Ltd (HAO)

Haoxi Health Technology Ltd. is a common stock listed on the NASDAQ exchange under the ticker HAO. Through its subsidiaries, the company provides online marketing solutions in China, with a focus on short video marketing and customized advertising services. Its work includes planning, producing, placing, and optimizing online ads for clients across digital platforms, helping advertisers reach consumers and support acquisition, conversion, and retention efforts. The company places advertisements on widely used online media platforms such as Toutiao, Douyin, WeChat, and Sina Weibo. Haoxi Health Technology primarily serves advertisers in the healthcare sector. Founded in 2018, the company is based in Chaoyang, China.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-HAO
$0.29
47.0% Upside
Undervalued
—
—
—
Weak
—
—
—
0.0%
October 20, 2026
-0.2x
0.0x
0.0x
464.064 K
-4.778 M
77.5%
85.5%
7.5
—
121.5%
Send a message
Valuation • Fair Value

Haoxi Health Technology Ltd (NASDAQ-HAO) Fair Value by Valuation Model

Compare the primary fair value estimate for Haoxi Health Technology Ltd (NASDAQ-HAO) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.29

Estimated upside of 47.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.29

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Haoxi Health Technology Ltd (NASDAQ-HAO) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Haoxi Health Technology Ltd (NASDAQ-HAO)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

42.678 M

Current operating scale indicator.

Revenue Forecast

32.804 M

Forward revenue estimate.

EBITDA

-7.051 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Haoxi Health Technology Ltd (NASDAQ-HAO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Haoxi Health Technology Ltd (NASDAQ-HAO)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-4.28

No elevated caution signal from this screen.

Altman Z-Score

7.5

Relatively strong balance-sheet zone.

FCF / Net Income

121.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Haoxi Health Technology Ltd (NASDAQ-HAO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Haoxi Health Technology Ltd (NASDAQ-HAO)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

October 20, 2026

Days to Earnings

91

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Haoxi Health Technology Ltd (NASDAQ-HAO), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Haoxi Health Technology Ltd (NASDAQ-HAO) Stock Forecast & Technical Outlook

Review Haoxi Health Technology Ltd (NASDAQ-HAO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Haoxi Health Technology Ltd (NASDAQ-HAO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Haoxi Health Technology Ltd (NASDAQ-HAO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Haoxi Health Technology Ltd (NASDAQ-HAO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Haoxi Health Technology Ltd (NASDAQ-HAO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Haoxi Health Technology Ltd (NASDAQ-HAO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Haoxi Health Technology Ltd (NASDAQ-HAO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Haoxi Health Technology Ltd (NASDAQ-HAO) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Haoxi Health Technology Ltd (NASDAQ-HAO) Stock FAQ

Quick answers about Haoxi Health Technology Ltd (NASDAQ-HAO) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.29
Estimated upside 47.0%
Valuation Rating
Undervalued
Estimated upside of 47.0%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Haoxi Health Technology Ltd (NASDAQ-HAO) is $0.29. This implies an estimated upside of 47.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 47.0% versus the current market price.

An analyst price target for Haoxi Health Technology Ltd (NASDAQ-HAO) is not currently available in the latest data file.

The current financial health read for Haoxi Health Technology Ltd (NASDAQ-HAO) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Haoxi Health Technology Ltd (NASDAQ-HAO) is October 20, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Haoxi Health Technology Ltd (NASDAQ-HAO) is -0.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Haoxi Health Technology Ltd is 464.064 K.

The current enterprise value listed for Haoxi Health Technology Ltd is -4.778 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Haoxi Health Technology Ltd is NASDAQ-HAO, and the stock is listed on NASDAQ.

Haoxi Health Technology Ltd (NASDAQ-HAO) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Haoxi Health Technology Ltd is 77.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Haoxi Health Technology Ltd is 85.5%. Free float helps investors understand how much of the share base is available for public trading.

Similar Media Stocks on NASDAQ View more

Fox Corp Class A (FOXA) Fox Corp Class A (FOXA)
Fox Corp Class B (FOX) Fox Corp Class B (FOX)
Charter Communications Inc (CHTR) Charter Communications Inc (CHTR)
News Corp A (NWSA) News Corp A (NWSA)
News Corp B (NWS) News Corp B (NWS)
Sirius XM Holding Inc (SIRI) Sirius XM Holding Inc (SIRI)
Paramount Skydance Corp (PSKY) Paramount Skydance Corp (PSKY)
The Trade Desk (TTD) The Trade Desk (TTD)
QMMM Holdings Ltd (QMMM) QMMM Holdings Ltd (QMMM)
Nexstar Media Group Inc (NXST) Nexstar Media Group Inc (NXST)
Versant Media Group Inc (VSNT) Versant Media Group Inc (VSNT)
Liberty Broadband Corp (LBRDP) Liberty Broadband Corp (LBRDP)
Liberty Broadband Srs A (LBRDA) Liberty Broadband Srs A (LBRDA)
Liberty Broadband Srs C (LBRDK) Liberty Broadband Srs C (LBRDK)
Magnite Inc (MGNI) Magnite Inc (MGNI)
Stagwell Inc (STGW) Stagwell Inc (STGW)
Criteo Sa (CRTO) Criteo Sa (CRTO)
Sinclair Inc (SBGI) Sinclair Inc (SBGI)
Scholastic Corporation (SCHL) Scholastic Corporation (SCHL)
IHeartMedia Inc Class A (IHRT) IHeartMedia Inc Class A (IHRT)
Pubmatic Inc (PUBM) Pubmatic Inc (PUBM)
Nexxen International Ltd DRC (NEXN) Nexxen International Ltd DRC (NEXN)
Advantage Solutions Inc (ADV) Advantage Solutions Inc (ADV)
AMC Networks Inc (AMCX) AMC Networks Inc (AMCX)